The former ESPN and MSNBC anchor had a restored T206 Honus Wagner with a mysterious provenance, it's now been slabbed as ...
The company argues that claims of underperformance should be judged against a meaningful, comparable benchmark.
Tango Therapeutics' strong 2026 rally reflects promising clinical progress, but its premium valuation puts upcoming study ...
Independent, vendor-agnostic survey benchmark evaluates NHS EPR advisory firms across optimisation, workflow redesign, implementation assurance, interoperability, data, managed support, trust and ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
The tables have turned for the U.S. biosimilars market. With more than a decade since the first FDA biosim approval, strong launches to biologic copies to AbbVie’s Humira, J&J’s Stelara and ...
When torrential rains submerged large parts of Accra on June 29, the floods exposed something deeper than blocked drains.
The investment trust highlighted gains from stakes in global companies controlling 'pinch points' amid AI bottlenecks and ...
Abstract Ghana 39;s building regulations mdash; most recently codified in GS 1207:2018 mdash; were calibrated against a set of environmental assumptions that coastal urbanization and climate change ...
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
4dOpinion
The big mistakes Andy Burnham must avoid in his first 20 days as Prime Minister – Brian Wilson
An unwillingness to learn lessons from the previous Labour government helped ensure Keir Starmer got off to a bad start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results